NCT06915246 2026-03-27A Study of Carmustine With and Without Ethanol in Subjects With LymphomaVIVUS LLCPhase 2 Recruiting49 enrolled
NCT03382977 2025-03-11Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsVBI Vaccines Inc.Phase 1/2 Recruiting98 enrolled